Related Experiment Videos
Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects.
Y Matsubara1, K Narisawa, K Tada
1Department of Biochemical Genetics, Tohoku University School of Medicine, Sendai, Japan.
European Journal of Pediatrics
|March 1, 1992
Summary
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, a common genetic disorder, can be detected in newborns. Early diagnosis through DNA testing on Guthrie cards is crucial for preventing severe health issues.
Area of Science:
- Genetics
- Metabolic Disorders
- Biochemistry
Background:
- Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is an inherited metabolic disorder.
- It can lead to severe health consequences, including Reye-like syndrome and sudden infant death.
- A specific mutation (Lys329Glu) is prevalent in Caucasian populations.
Purpose of the Study:
- To highlight the significance of the common MCAD gene mutation.
- To emphasize the need for population screening due to high carrier prevalence.
- To discuss the utility of DNA diagnostic methods for early detection.
Main Methods:
- Identification of the most common MCAD gene mutation (Lys329Glu).
- Carrier prevalence screening in newborns across England, Australia, and the USA.
- DNA diagnostic methods utilizing Guthrie cards for mutation detection.
Main Results:
- The Lys329Glu substitution accounts for ~90% of MCAD mutant alleles in Caucasians.
- Carrier prevalence ranges from 1 in 40 to 1 in 107 in screened populations.
- Clinical heterogeneity observed in patients suggests factors beyond genetic variation.
Conclusions:
- The high incidence of MCAD deficiency warrants consideration for population-wide newborn screening.
- Early diagnosis via DNA testing on Guthrie cards enables timely dietary management.
- Efficient screening methods facilitate the detection of this potentially fatal disorder.